Novadaq Technologies Inc. 

(Public, TSE:NDQ)   Watch this stock   
Find more results for NDQ

Key stats and ratios

Q2 (Jun '09) 2008
Net profit margin -197.76% -135.78%
Operating margin -189.46% -138.02%
EBITD margin - -118.13%
Return on average assets -51.04% -52.15%
Return on average equity -82.87% -64.24%
Employees 20 -

Address

2585 Skymark Avenue Suite 306
Missisauga, ON L4W 4L5
Canada
+1-905-6293822 (Phone)
+1-905-6290282 (Fax)

Website links

Novadaq Technologies Inc. discussions

  View all discussions »

Description

Novadaq Technologies Inc. (Novadaq) develops and markets medical imaging and treatment systems for use in the operating room. The Company’s technology (SPY System) allows surgeons to assess tissue perfusion in real time at the time of surgery. The SPY System allows cardiac surgeons to capture, review, print and archive highquality, image sequences of coronary arteries, in real-time during a Coronary Artery Bypass Graft (CABG) procedure. Novadaq also distributes PLC Medical System Inc.’s HEART LASER SYSTEM (CO2 Laser) for transmyocardial revascularization (TMR) in the United States.

Officers and directors

Anthony F. Griffiths
Chairman of the Board
Arun Menawat
President, Chief Executive Officer, Director
Stephen Purcell
Chief Financial Officer
Rick Mangat
Senior Vice President, General Manager
Roger Deck
Vice President - Operations
John Fengler
Vice President - Research & Development
Mary Kay Baggs
Vice President - Business Development
Aaron Davidson
Director
Age: 38
Harold O. Koch Jr.
Director
Brent Norton
Director